Human rotavirus vaccine <it>Rotarix</it>™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Rotaviruses are the most important cause of severe acute gastroenteritis worldwide in children <5 years of age. The human, G1P[8] rotavirus vaccine <it>Rotarix</it>™ significantly reduced severe rotavirus gastroenterit...
Main Authors: | Steele Andrew, Neuzil Kathleen M, Cunliffe Nigel A, Madhi Shabir A, Bos Pieter, Ngwira Bagrey, Witte Desiree, Todd Stacy, Louw Cheryl, Kirsten Mari, Aspinall Sanet, Van Doorn Leen, Bouckenooghe Alain, Suryakiran Pemmaraju V, Han Htay |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/12/213 |
Similar Items
-
Immunogenicity, reactogenicity, and safety of a human rotavirus vaccine, Rotarix, in Taiwanese infants who received a dose of hepatitis B immunoglobulin after birth
by: Chun-Yi Lu, et al.
Published: (2013-09-01) -
Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.
by: Innocent Mwape, et al.
Published: (2017-01-01) -
RIX4414 (Rotarix™): uma vacina contra o rotavírus humano com vírus vivo atenuado RIX4414 (Rotarix ™): a live attenuated human rotavirus vaccine
by: David I. Bernstein
Published: (2007-06-01) -
Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
by: Frédéric Debellut, et al.
Published: (2020-01-01) -
Monitoring the circulation of rotavirus among children after the introduction of the RotarixTM vaccine in Goiânia, Brazil
by: Ana Maria Tavares Borges, et al.
Published: (2011-06-01)